High protective efficacy of probiotics and rice bran against human norovirus infection and diarrhea in gnotobiotic pigs

Frontiers in Microbiology

Volumn 7, Issue NOV, 2016, Pages

  Lei, Shaohua ^a   Ramesh, Ashwin ^a   Twitchell, Erica ^a   Wen, Ke ^a   Bui, Tammy ^a   Weiss, Mariah ^a   Yang, Xingdong ^a   Kocher, Jacob ^a   Li, Guohua ^a   Giri Rachman, Ernawati ^a,b   Van Trang, Nguyen ^c   Jiang, Xi ^d   Ryan, Elizabeth P ^e   Yuan, Lijuan ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

^c National Institute of Hygiene and Epidemiology   (Viet Nam)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Diarrhea; Gnotobiotic pigs; Human norovirus; Probiotics; Rice bran

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROBIOTIC AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; FLOW CYTOMETRY; GASTROENTERITIS; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNITY; JEJUNUM; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; LOW DRUG DOSE; MALE; MICROBIAL COLONIZATION; NONHUMAN; NOROVIRUS INFECTION; NUCLEOTIDE SEQUENCE; PIG; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RICE BRAN; SCANNING TRANSMISSION ELECTRON MICROSCOPY; SEQUENCE ANALYSIS; T LYMPHOCYTE; VIRION; VIRUS SHEDDING;

EID: 85006713584     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.01699     Document Type: Article

References (61)

1. Ahmed, S. M., Hall, A. J., Robinson, A. E., Verhoef, L., Premkumar, P., Parashar, U. D., et al. (2014). Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect. Dis. 14, 725-730. doi: 10.1016/S1473-3099(14)70767-4.
2. Atmar, R. L., Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., et al. (2011).Norovirus vaccine against experimental human Norwalk Virus illness. N. Engl. J. Med. 365, 2178-2187. doi: 10.1056/NEJMoa1101245.
3. Ayouni, S., Estienney, M., Sdiri-Loulizi, K., Ambert-Balay, K., de Rougemont, A., Aho, S., et al. (2015).Relationship between GII.3 norovirus infections and blood group antigens in young children in Tunisia. Clin. Microbiol. Infect. 21, e871-e878. doi: 10.1016/j.cmi.2015.05.015.
4. Baldridge, M. T., Nice, T. J., McCune, B. T., Yokoyama, C. C., Kambal, A., Wheadon, M., et al. (2015).Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science 347, 266-269. doi: 10.1126/science.1258025.
5. Botic, T., Klingberg, T. D., Weingartl, H., and Cencic, A. (2007).A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Int. J. Food Microbiol. 115, 227-234. doi: 10.1016/j.ijfoodmicro.2006.10.044.
6. Bresee, J. S., Marcus, R., Venezia, R. A., Keene, W. E., Morse, D., Thanassi, M., et al. (2012).The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States. J. Infect. Dis. 205, 1374-1381. doi: 10.1093/infdis/jis206.
7. Bui, T., Kocher, J., Li, Y., Wen, K., Li, G., Liu, F., et al. (2013).Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age. J. Gen. Virol. 94, 2005-2016. doi: 10.1099/vir.0.054080-0.
8. Cadwell, K., Patel, K. K., Maloney, N. S., Liu, T. C., Ng, A. C., Storer, C. E., et al. (2010).Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135-1145. doi: 10.1016/j.cell.2010.05.009.
9. Chand, N., and Mihas, A. A. (2006).Celiac disease: current concepts in diagnosis and treatment. J. Clin. Gastroenterol. 40, 3-14. doi: 10.1097/01.mcg.0000190644.01661.2b.
10. Cheetham, S., Souza, M., Meulia, T., Grimes, S., Han, M. G., and Saif, L. J. (2006).Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J. Virol. 80, 10372-10381. doi: 10.1128/JVI.00809-06.
11. Debbink, K., Lindesmith, L. C., and Baric, R. S. (2014).The state of norovirus vaccines. Clin. Infect. Dis. 58, 1746-1752. doi: 10.1093/cid/ciu120.
12. Green, K. Y. (2014).Norovirus infection in immunocompromised hosts. Clin. Microbiol. Infect. 20, 717-723. doi: 10.1111/1469-0691.12761.
13. Guandalini, S., Pensabene, L., Zikri, M. A., Dias, J. A., Casali, L. G., Hoekstra, H., et al. (2000).Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 30, 54-60. doi: 10.1097/00005176-200001000-00018.
14. Guix, S., Asanaka, M., Katayama, K., Crawford, S. E., Neill, F. H., Atmar, R. L., et al. (2007).Norwalk virus RNA is infectious in mammalian cells. J. Virol. 81, 12238-12248. doi: 10.1128/JVI.01489-07.
15. Hall, A. J., Curns, A. T., McDonald, L. C., Parashar, U. D., and Lopman, B. A. (2012). The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin. Infect. Dis. 55, 216-223. doi: 10.1093/cid/cis386.
16. Henderson, A. J., Kumar, A., Barnett, B., Dow, S. W., and Ryan, E. P. (2012).Consumption of rice bran increases mucosal immunoglobulin A concentrations and numbers of intestinal Lactobacillus spp. J. Med. Food 15, 469-475. doi: 10.1089/jmf.2011.0213.
17. Henker, J., Laass, M., Blokhin, B. M., Bolbot, Y. K., Maydannik, V. G., Elze, M., et al. (2007).The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur. J. Pediatr. 166, 311-318. doi: 10.1007/s00431-007-0419-x.
18. Henker, J., Laass, M. W., Blokhin, B. M., Maydannik, V. G., Bolbot, Y. K., Elze, M., et al. (2008).Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers. Pediatr. Infect. Dis. J. 27, 494-499. doi: 10.1097/INF.0b013e318169034c.
19. Hering, N. A., Richter, J. F., Fromm, A., Wieser, A., Hartmann, S., Gunzel, D., et al. (2014).TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCzeta and ERK1/2 signaling in HT-29/B6 cells. Mucosal Immunol. 7, 369-378. doi: 10.1038/mi.2013.55.
20. Hodges, K., and Gill, R. (2010).Infectious diarrhea: cellular and molecular mechanisms. Gut Microbes 1, 4-21. doi: 10.4161/gmic.1.1.11036.
21. Jones, M. K., Watanabe, M., Zhu, S., Graves, C. L., Keyes, L. R., Grau, K. R., et al. (2014).Enteric bacteria promote human and mouse norovirus infection of B cells. Science 346, 755-759. doi: 10.1126/science.1257147.
22. Kageyama, T., Kojima, S., Shinohara, M., Uchida, K., Fukushi, S., Hoshino, F. B., et al. (2003).Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J. Clin. Microbiol. 41, 1548-1557. doi: 10.1128/JCM.41.4.1548-1557.2003.
23. Kamiya, T., Shikano, M., Tanaka, M., Ozeki, K., Ebi, M., Katano, T., et al. (2014).Therapeutic effects of biobran, modified arabinoxylan rice bran, in improving symptoms of diarrhea predominant or mixed type irritable bowel syndrome: a pilot, randomized controlled study. Evid. Based Complement. Alternat. Med. 2014:828137. doi: 10.1155/2014/828137.
24. Kandasamy, S., Vlasova, A. N., Fischer, D., Kumar, A., Chattha, K. S., Rauf, A., et al. (2016).Differential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus strain GG on human rotavirus binding, infection, and B cell immunity. J. Immunol. 196, 1780-1789. doi: 10.4049/jimmunol.1501705.
25. Kocher, J., Bui, T., Giri-Rachman, E., Wen, K., Li, G., Yang, X., et al. (2014). Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs. J. Virol. 88, 9728-9743. doi: 10.1128/JVI.01249-14.
26. Kocher, J., and Yuan, L. (2015).Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives. Future Virol. 10, 899-913. doi: 10.2217/fvl.15.57.
27. Lee, H., and Ko, G. (2016).Antiviral effect of vitamin A on norovirus infection via modulation of the gut microbiome. Sci. Rep. 6:25835. doi: 10.1038/srep25835.
28. Lee, R. M., Lessler, J., Lee, R. A., Rudolph, K. E., Reich, N. G., Perl, T. M., et al. (2013).Incubation periods of viral gastroenteritis: a systematic review. BMC Infect. Dis. 13:446. doi: 10.1186/1471-2334-13-446.
29. Lei, S., Ryu, J., Wen, K., Twitchell, E., Bui, T., Ramesh, A., et al. (2016a).Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency. Sci. Rep. 6:25222. doi: 10.1038/srep25222.
30. Lei, S., Samuel, H., Twitchell, E., Bui, T., Ramesh, A., Wen, K., et al. (2016b).Enterobacter cloacae inhibits human norovirus infectivity in gnotobiotic pigs. Sci. Rep. 6:25017. doi: 10.1038/srep25017.
31. Licciardi, P. V., and Tang, M. L. (2011).Vaccine adjuvant properties of probiotic bacteria. Discov. Med. 12, 525-533.
32. Liu, P., Wang, X., Lee, J. C., Teunis, P., Hu, S., Paradise, H. T., et al. (2014).Genetic susceptibility to norovirus GII.3 and GII.4 infections in Chinese pediatric diarrheal disease. Pediatr. Infect. Dis. J. 33, e305-e309. doi: 10.1097/INF.0000000000000443.
33. Lopman, B. A., Reacher, M. H., Vipond, I. B., Sarangi, J., and Brown, D. W. (2004).Clinical manifestation of norovirus gastroenteritis in health care settings. Clin. Infect. Dis. 39, 318-324. doi: 10.1086/421948.
34. Maragkoudakis, P. A., Chingwaru, W., Gradisnik, L., Tsakalidou, E., and Cencic, A. (2010).Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection. Int. J. Food Microbiol. 141(Suppl. 1), S91-S97. doi: 10.1016/j.ijfoodmicro.2009.12.024.
35. Meyer, R. C., Bohl, E. H., and Kohler, E. M. (1964).Procurement and maintenance of germ-free seine for microbiological investigations. Appl. Microbiol. 12, 295-300.
36. Miura, T., Sano, D., Suenaga, A., Yoshimura, T., Fuzawa, M., Nakagomi, T., et al. (2013).Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses. J. Virol. 87, 9441-9451. doi: 10.1128/JVI.01060-13.
37. Murata, T., Katsushima, N., Mizuta, K., Muraki, Y., Hongo, S., and Matsuzaki, Y. (2007).Prolonged norovirus shedding in infants < or = 6 months of age with gastroenteritis. Pediatr. Infect. Dis. J. 26, 46-49. doi: 10.1097/01.inf.0000247102.04997.e0.
38. Ng, S. C., Hart, A. L., Kamm, M. A., Stagg, A. J., and Knight, S. C. (2009).Mechanisms of action of probiotics: recent advances. Inflamm. Bowel Dis. 15, 300-310. doi: 10.1002/ibd.20602.
39. Park, H. Y., Yu, A. R., Hong, H. D., Kim, H. H., Lee, K. W., and Choi, H. D. (2016).Immunomodulatory effects of nontoxic glycoprotein fraction isolated from rice bran. Planta Med. 82, 606-611. doi: 10.1055/s-0042-101944.
40. Patel, M. M., Widdowson, M. A., Glass, R. I., Akazawa, K., Vinje, J., and Parashar, U. D. (2008).Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis. 14, 1224-1231. doi: 10.3201/eid1408.071114.
41. Payne, D. C., Vinje, J., Szilagyi, P. G., Edwards, K. M., Staat, M. A., Weinberg, G. A., et al. (2013).Norovirus and medically attended gastroenteritis in U.S. children. N. Engl. J. Med. 368, 1121-1130. doi: 10.1056/NEJMsa1206589.
42. Pringle, K., Lopman, B., Vega, E., Vinje, J., Parashar, U. D., and Hall, A. J. (2015).Noroviruses: epidemiology, immunity and prospects for prevention. Future Microbiol. 10, 53-67. doi: 10.2217/fmb.14.102.
43. Ray, B., Hutterer, C., Bandyopadhyay, S. S., Ghosh, K., Chatterjee, U. R., Ray, S., et al. (2013).Chemically engineered sulfated glucans from rice bran exert strong antiviral activity at the stage of viral entry. J. Nat. Prod. 76, 2180-2188. doi: 10.1021/np4003977.
44. Rubio-del-Campo, A., Coll-Marques, J. M., Yebra, M. J., Buesa, J., Perez-Martinez, G., Monedero, V., et al. (2014).Noroviral p-particles as an in vitro model to assess the interactions of noroviruses with probiotics. PLoS ONE 9:e89586. doi: 10.1371/journal.pone.0089586.
45. Schnadower, D., Finkelstein, Y., and Freedman, S. B. (2015).Ondansetron and probiotics in the management of pediatric acute gastroenteritis in developed countries. Curr. Opin. Gastroenterol. 31, 1-6. doi: 10.1097/MOG.0000000000000132.
46. Schroeder, B., Duncker, S., Barth, S., Bauerfeind, R., Gruber, A. D., Deppenmeier, S., et al. (2006).Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. Dig. Dis. Sci. 51, 724-731. doi: 10.1007/s10620-006-3198-8.
47. Sheflin, A. M., Borresen, E. C., Wdowik, M. J., Rao, S., Brown, R. J., Heuberger, A. L., et al. (2015).Pilot dietary intervention with heat-stabilized rice bran modulates stool microbiota and metabolites in healthy adults. Nutrients 7, 1282-1300. doi: 10.3390/nu7021282.
48. Sindhu, K. N., Sowmyanarayanan, T. V., Paul, A., Babji, S., Ajjampur, S. S., Priyadarshini, S., et al. (2014).Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 58, 1107-1115. doi: 10.1093/cid/ciu065.
49. Splichalova, A., Trebichavsky, I., Rada, V., Vlkova, E., Sonnenborn, U., and Splichal, I. (2011).Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine. Clin. Exp. Immunol. 163, 242-249. doi: 10.1111/j.1365-2249.2010.04283.x.
50. Szajewska, H., Urbanska, M., Chmielewska, A., Weizman, Z., and Shamir, R. (2014).Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef. Microbes 5, 285-293. doi: 10.3920/BM2013.0056.
51. Tan, M., Fang, P., Chachiyo, T., Xia, M., Huang, P., Fang, Z., et al. (2008).Noroviral P particle: structure, function and applications in virus-host interaction. Virology 382, 115-123. doi: 10.1016/j.virol.2008.08.047.
52. Tan, M., and Jiang, X. (2005).The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J. Virol. 79, 14017-14030. doi: 10.1128/JVI.79.22.14017-14030.2005.
53. Van Trang, N., Vu, H. T., Le, N. T., Huang, P., Jiang, X., and Anh, D. D. (2014).Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. J. Clin. Microbiol. 52, 1366-1374. doi: 10.1128/JCM.02927-13.
54. von Buenau, R., Jaekel, L., Schubotz, E., Schwarz, S., Stroff, T., and Krueger, M. (2005).Escherichia coli strain Nissle 1917: significant reduction of neonatal calf diarrhea. J. Dairy Sci. 88, 317-323. doi: 10.3168/jds.S0022-0302(05)72690-4.
55. Wen, K., Liu, F., Li, G., Bai, M., Kocher, J., Yang, X., et al. (2015).Lactobacillus rhamnosus GG dosage affects the adjuvanticity and protection against rotavirus Diarrhea in Gnotobiotic Pigs. J. Pediatr. Gastroenterol. Nutr. 60, 834-843. doi: 10.1097/MPG.0000000000000694.
56. Wen, K., Tin, C., Wang, H., Yang, X., Li, G., Giri-Rachman, E., et al. (2014).Probiotic Lactobacillus rhamnosus GG enhanced Th1 cellular immunity but did not affect antibody responses in a human gut microbiota transplanted neonatal gnotobiotic pig model. PLoS ONE 9:e94504. doi: 10.1371/journal.pone.0094504.
57. Yang, X., Twitchell, E., Li, G., Wen, K., Weiss, M., Kocher, J., et al. (2015).High protective efficacy of rice bran against human rotavirus diarrhea via enhancing probiotic growth, gut barrier function, and innate immunity. Sci. Rep. 5:15004. doi: 10.1038/srep15004.
58. Yang, X., Wen, K., Tin, C., Li, G., Wang, H., Kocher, J., et al. (2014).Dietary rice bran protects against rotavirus diarrhea and promotes Th1-type immune responses to human rotavirus vaccine in gnotobiotic pigs. Clin. Vaccine Immunol. 21, 1396-1403. doi: 10.1128/CVI.00210-14.
59. Yang, X., and Yuan, L. (2014).Neonatal gnotobiotic pig models for studying viral pathogenesis, immune responses, and for vaccine evaluation. Br. J. Virol. 1, 87-91. doi: 10.1371/journal.pone.0094504.
60. Yuan, L., Wen, K., Azevedo, M. S., Gonzalez, A. M., Zhang, W., and Saif, L. J. (2008).Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs. Vaccine 26, 3322-3331. doi: 10.1016/j.vaccine.2008.03.085.
61. Zhang, W., Azevedo, M. S., Wen, K., Gonzalez, A., Saif, L. J., Li, G., et al. (2008).Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs. Vaccine 26, 3655-3661. doi: 10.1016/j.vaccine.2008.04.070.